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Original Article
Abstract
Background and aims: Although chronic bronchitis is markedly under-diagnosed in the general 
population, it has a significant impact on the health status and the well-being of patients as well as 
healthcare resource consumption. This study aimed to determine the prevalence of chronic bronchitis 
and its correlates in the northwest of Iran.
Methods: In 2014, all residents aged 35 and over in Khameneh city, East Azerbaijan, were invited to 
participate in the pilot phase of the Azar cohort study. The respiratory symptoms questionnaires were 
filled out by two trained general practitioners. Participants with a cough and phlegm on most days 
during at least three successive months in the previous two years were classified as chronic bronchitis 
group.  Chi-square test was used to compare the chronic bronchitis and smoking status between males 
and females.
Results:  A total of 1036 participants were interviewed, 1006 of whom had completed a respiratory 
questionnaire, from them 544 (54.1%) were females, and 462 (45.9%) were males.  The mean age 
was 52.5 ± 10.5 years. The prevalence of smoking was 16.2%. According to the chronic bronchitis 
definition, 24 (2.4%) subjects were classified with chronic bronchitis, and the prevalence was higher 
in the males (4.1%) than that in the females (0.9%). The prevalence was higher among the active 
smokers and ex-smokers compared to non- smokers (8.6% and 4.1% vs. 0.8%). The prevalence of 
cigarette smoking was 16.2% and it was higher in the males than that in the females (33.5% vs. 1.5%). 
Conclusion: the prevalence of chronic bronchitis in the population of the region under study was 
relatively low in comparison to the other parts of Iran and its prevalence was higher in the males than 
that in the females. 
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Introduction
Chronic bronchitis (CB) implies the chronic inflammation 
of the bronchi which causes the swelling and irritation of the 
respiratory pathways as well as increased mucus production.1 
It does not necessarily imply the presence of infection.2 
CB is a common disease among the general population, 
especially among the middle-aged and elderly groups.3,4 It 
affects not only about a third of the patients with chronic 
obstructive pulmonary disease (COPD), but also occurs in 
the individuals with normal lung function.5 The estimates 
indicated that the incidence of CB has been increasing, 
particularly in developing countries.4 CB accounts for high 
morbidity and mortality throughout the world, though it is 
a preventable disease.6 
The most common cause of CB, cigarette smoking, 
increases the risk of getting CB during the smokers’ lifetime, 
as over 40% of the smokers develop CB.7 Air pollution and 
dust, or toxic gases in the environment or workplace, and low 
socioeconomic status can also contribute to the condition.6,8 
Various reports have been received from different parts of 
Iran on the prevalence of CB. For example, in the study of 
Golshan and colleagues conducted in 2001, the prevalence 
of CB was 4.66%,9 but in another study conducted in 
2011, the prevalence was increased to 8.18%.10 Moreover, 
in a study in Tehran, the prevalence of CB was reported 
high (10.9%),11 while in the study of Amra and Hashemiin 
Shahrekord, the prevalence was reported low (1.8%).12 
According to the result of a meta-analysis in 2016, the 
prevalence of CB in Iran was 5.57%.11 There are limited 
studies about the prevalence of CB and cigarette smoking 
status in East Azerbaijan; in this regard, this study may help 
to determine the extent and burden of CB in the region. 
Therefore, this study aimed to determine the prevalence of 
CB and cigarette smoking in the adults of Khamaneh city, 
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East Azerbaijan, and the smoking status in the subjects who 
had CB. 
Methods 
The present study was conducted based on the pilot phase 
of the Azar cohort study. The Azar cohort study is the state-
level of a nationwide cohort study entitled “PERSIAN 
Cohort Study’ in Iran that launched in 2014 in different 
geographical regions of Iran.13 The Azar cohort study has 
been conducted by Tabriz University of Medical Sciences 
in Shabestar, a county located in the province of East 
Azerbaijan. All adults aged 35 to 70 years were invited to 
take part in this study if they met the inclusion criteria 
(permanent resident of the city, ability to respond to the 
questions, being Iranian). The pilot phase of the Azar cohort 
study was conducted in Khameneh, one of the cities in 
Shabestar county, between October 2014 and January 2015. 
All residents of Khameneh who were 35 years old and older 
(n= 1236) were invited by phone to participate in the pilot 
phase of the study. The respiratory symptoms questionnaires 
were filled out by 2 trained general practitioners. For 
epidemiological purposes, CB was only diagnosed through 
the questionnaire.14 The respiratory symptom questions 
were extracted from the Framingham’s questionnaire 
(original cohort-exam 29- form, and generation 3 exam 1 
& 2-form).15 The questionnaire contained the information 
about the respiratory symptoms (e.g., dyspnea, cough, 
sputum production, and cough duration), exposure to 
potential risk factors such as smoking, occupational 
exposures, respiratory diseases, comorbidities, medication 
history, and health status. Spirometry was also done to all 
those for whom the questionnaires were filled out, but due 
to technical issues, spirometry data were not used.
Respiratory physical examinations were also carried out. 
The diagnosis of CB was only made when the physician was 
satisﬁed that the patient had a chronic productive cough for 
at least 3 consecutive months in the previous 2 years.16,17 
The following questions were asked from the study subjects: 
“Are there months in which you cough on most days?”, “Is 
your cough persistent or intermittent?”, “Do not you cough 
most days for 3 months every year?”, “For how many years 
have you had this cough?”, “Do you have a productive 
cough or a dry cough?” and “Has your doctor ever said you 
have had CB?” 
Smoking status was classified as non-smoker (someone 
who never smoked or smoked fewer than 100 cigarettes in 
his/her lifetime), ex-smoker (someone who has not smoked 
for 6 months and more), and current smoker (someone who 
currently smokes one or more cigarettes per day). Age was 
classified into 3 categories: <45, 45-65, and >65 years old. 
Statistical Analysis
Descriptive statistics were calculated for all variables. 
Quantitative variables were presented as the mean ± standard 
deviation (SD), and categorical variables as numbers 
with a percentage. The distribution of mean age was not 
normal (normality was checked with Kolmogorov-Smirnov 
test). Therefore, the Mann-Whitney U test was used to 
compare the mean age between the males and females. Chi-
square (χ2) test was also used to compare the age group, 
smoking status, and CB between the males and females. 
Factors associated with the presence of CB symptoms were 
examined by univariate and multivariate logistic regressions, 
with the following covariates as potential risk factors such 
as age, sex, smoking status, and exposure to passive smoke. 
SPSS software version 15.0 (SPSS Inc., Chicago, Illinois, 
USA) was used to analyze data. A P value less than 0.05 was 
regarded as statistically significant.
Results 
A total of 1236 adults aged 35 to 70 were invited to 
participate in the Azar cohort study. A number of 1038 
people participated in the study (with 84% participation 
rate) and the respiratory questionnaire was completed for 
1006 individuals. Of the 1006 individuals, 544 (54.1%) 
were female and 462 (45.9%) were male. The mean age was 
52.5 ± 10.5 years. A history of current or past smoking was 
more frequent in the males than that in the females. Of all 
participants, 163 (16.2%) were smokers; out of which, 155 
(33.5%) were male and 8 (1.5%) were female; 99 (9.8%) 
were ex-smokers. The prevalence of CB (in adults aged ≥35 
years) was 2.4% and was higher in the males (4.1%) than 
that in the females (0.9%) (Table 1).
Seventy-nine percent of the individuals who had CB were 
male. The prevalence of CB was higher among the active 
smokers and ex-smokers compared to non-smokers (8.6% 
and 4.1% vs. 0.8%). The prevalence of cigarette smoking 
was 16.2% and was higher in the males than that in the 
females (33.5% vs. 1.5%). Furthermore, hookah smoking 
was higher in the males than that in the females (3.5% vs. 
0.6%) (Table 2).
The frequency of respiratory symptoms in the present 
study population is presented in Table 3. The most 
commonly reported respiratory symptoms were dyspnea, 
cough, sputum production, and wheeze, respectively.
Table 4 shows the unadjusted odds ratios associated with 
each variable and those adjusted odds ratios with some 
variables in the model including age, gender, and smoking 
status. 
Although in univariate logistic regression analysis, the 
relation between sex and CB was positive and significant 
(Odds ratio [OR]=4.62, P= 0.003), that is, the chance of 
CB was 4.6 times higher in the men than that in the women, 
in the multivariate analysis, this relation was not significant 
(OR=1.85, P= 0.30). In the univariate analysis, the relation 
between old age (>60 years old) and CB was not statistically 
significant (OR= 2.76, P= 0.99), but it was significant in 
multivariate analysis (OR=4, P=0.04). Both univariate and 
multivariate analyses revealed that CB was related to the 
cigarette smoking (P<0.05) and the chance of CB in the 
current smokers was 12.5 times higher than that in the non-
smokers (OR= 12.5, P<0.001). Our results showed that 
there was no relationship between hookah smoking, a local 
form of smoking known as Ghalian, and CB, because the 
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frequency of hookah smoking was zero among our patients 
with CB.
Discussion
CB, which is markedly under-diagnosed in the general 
population, has a significant impact on the health status 
and well-being of patients, and the healthcare resource 
consumption.18-20 The prevalence of CB varies from country 
to country. On average, CB is seen in 3.4% to 22.0% of 
adults. This various estimation of CB prevalence may be 
Table 1. Characteristics of the Study Population
Variables Total Number (%) Number of Males (%) Number of Females (%) P Value
Number of participants 1006 462 (45.9) 544 (54.1) -
Age (mean± SD) 52.5±10.3 53.42±10.47 51.72±10.22 0.003
Age groups 0.108
<45 years old 269 (26.7) 110 (23.8) 159 (29.2)
45-65 years old 616 (61.2) 290 (62.8) 326 (59.9)  
>65 years old 121 (12) 62 (13.4) 5 (48.8)
Smoking habits
Smoking history (+) 262 (26) 250 (54.1) 12 (2.2) <0.001
Current smoker 163 (16.2) 155 (33.5) 8 (1.5) <0.001
Ex-smoker 99 (9.8) 95 (20.6) 4 (0.7) <0.001
Never smokera 744 (74) 212 (45.9) 532 (97.8) <0.001
Passive smoker at home 166 (16) 22 (13.3) 144 (86.7) <0.001 
Passive smoker in childhoodb 493 (49) 255 (55.3) 238 (43.8) <0.001 
Hookah smoker 19 (1.8) 16 (3.5) 3 (0.6) 0.001 
CB 24 (2.4) 19 (4.1) 5 (0.9) 0.001
Abbreviations:  SD, standard deviation; CB, chronic bronchitis.
a Someone who never smoked or smoked fewer than 100 cigarettes in their lifetime; b Someone who had exposure to parental smoking.
Table 2. Prevalence of Chronic Bronchitis Adjusted by Smoking, Sex, 
and Age
Variables No. of Subjects Prevalence of CB (%) P Value
Total 1006 2.4
Smoking habits <0.001
Current smoker 163 8.6
Ex-smoker 99 4.1
Never smoker 744 0.8
Gender 0.001
Male 462 4.1
Female 544 0.9     
Age 0.11
<45 years old 269 1.5
45-65 years old 616 2.3
>65 years old 121  5.0
Male with age 0.14  
<45 years old 110 1.8
45-65 years old 290 4.1
>65 years old 62 8.1
Female with age 0.63
<45 years old 159 1.3
45-65 years old 326 0.6
>65 years old 59 1.7
Table 3. Prevalence of Respiratory Symptoms in the Study Population 
(n = 1006)
Respiratory Symptoms Number (%)
Dyspnea  88 (8.7)
Sputum production 30 (3)
Cough 66 (6.6)
Dry cough 40 (4)
Persistent cough 9 (0.9)
Intermittent cough 52 (5.2)
Wheeze 14 (1.4)
due to various CB definitions (i.e., chronic sputum versus 
chronic cough and sputum).2 In the patients with COPD, 
the prevalence of CB is higher, affecting 14% to 74% of 
all the patients with COPD.21 In a 30-year longitudinal 
study on middle-aged men, the cumulative incidence of 
CB was 42% in current smokers, 26% in ex-smokers, and 
22% in never smokers.22 In a survey conducted to determine 
the burden of CB in the general population of France, the 
results showed that the prevalence of CB was 3.5% among 
the French population aged ≥40 years 20. In Canada, the 
prevalence of CB in adults was 2.5%.1 However, in India, 
the prevalence among the individuals aged ≥40 years was 
higher compared to the individuals aged <40 years ( 10% 
vs. 8.5%).23 A survey in Finland showed that during the last 
3 decades (between 1986 and 2007), the prevalence of CB 
decreased from 19% in 1982 to 13% in 2007 (P for trend 
<0.001).24
 In Iran, the studies conducted in Shahrekord and Isfahan 
revealed that the prevalence of CB was 1.8% and 8.1%, 
respectively.10,12 During the period between 1999 and 2010 
in Isfahan, the prevalence of CB significantly increased. The 
causes of this phenomenon might be related to the increased 
air pollution both from traffic sources and industries.9,10 
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The findings of a meta-analysis in Iran showed that the 
prevalence of CB was 5.6%. However, in the present study, 
the prevalence of CB among Khameneh adults was found 
to be 2.4% based on clinical symptoms. Given the fact that 
Khamene is a small city with low air pollution, the low 
prevalence of CB in this city is justified.
In comparison, the prevalence of CB in the different parts 
of Turkey, a neighboring country of Iran, was higher than 
that in this study (11.7% in Istanbul, 17.7% in Ankara, 
13.5% in Kayseri). One reason for this finding may be 
related to the higher consumption of biomass fuels in these 
areas4. In places where women use biomass fuels for cooking, 
the prevalence of respiratory symptoms and CB is higher.25
Many studies have demonstrated that CB affects men 
more than women.26,27 Studies conducted on the American 
and Chinese population showed that male gender was more 
associated with the presence of CB.28,29 On the contrary, 
according to the report of the National Center for Health 
Statistics (2009), 67.8% of the patients with CB were 
women.28 In some rural areas where women encountered 
domestic smoke pollution during cooking, this rate was even 
higher.14 Our findings showed that the higher prevalence of 
CB in men was statistically related to higher smoking in 
them. 
In a survey conducted in the US, the highest prevalence 
of CB was seen among the subjects aged 65 and older,28 
but in our study, the highest prevalence was observed 
among middle-aged people. Although smoking is the most 
important risk factor for CB, and as mentioned earlier, the 
30-year cumulative incidence of CB among current smokers 
is 42%,22,30 factors other than smoking may also contribute 
to CB including exposure to inhalation of biomass fuels, 
chemical gases, and dust.31,32 Smoking cessation can decrease 
cough in many patients with CB by improving mucociliary 
function and by decreasing goblet cell hyperplasia.33 An 
extensive longitudinal follow-up study found that the 
incidence rate of CB was much higher in current smokers 
compared to ex-smokers (42% vs. 26%).22,34
In a review article about cigarette smoking in Iran, the 
prevalence of cigarette smoking in Iran was found to range 
from 0.4% to 41%,35 and the result of a meta-analysis in 
Iran showed that one-fifth of Iranian men ( 20%) and 2%-
3% of women have daily smoking habits. According to this 
meta-analysis, smoking prevalence among Iranian women 
is higher than that in some Islamic countries such as Egypt, 
Kuwait, Saudi Arabia, and Oman, and is similar to Singapore, 
Malaysia, and China; although it is lower than Italy, America, 
and Australia.36 Due to some cultural pressures such as 
stigma, in Iran and other Islamic countries, the prevalence 
of cigarette and hookah smoking among women in all age 
groups is significantly lower than that among men.36- 38 In 
the present study, the prevalence of smoking among women 
was also very low (1.5%) in comparison to men (33.5%). 
Indeed, one-third of men in Khameneh city were smokers. 
The prevalence of hookah smoking in this population was 
low (1.8%) because the hookah smoking culture in the 
northwest of Iran is less common.
Given the fact that smokers start smoking from adolescence 
and early adulthood,39,40 if these age groups were included in 
our study, the prevalence of smoking would be higher than 
our estimate. Tobacco use is a risk factor for 6 out of the 8 
leading causes of death, such as heart disease, several cancer 
Table 4. Relationship Between Chronic Bronchitis, Sex, Age, and Smoking (n = 24)
Variables Total
 Unadjusted  Adjusted
Odds Ratio P Value Odds Ratio P Value
Gender
Male 19 4.62 0.003 1.85 0.30
Female 5 Reference
Age
<45 years old 5 (20.8%) Reference Reference
45-65 years old 13 (54.2%) 1.14 0.79 1.43 0.53
>65 years old 6 (25%) 2.76 0.99 4.00 0.040
Smoking habits
Smoking history (+) 18 9.07 <0.001 8.61 0.002
Smoking history (-) 6 Reference - Reference -
Current smoker (+) 14 7.82 <0.001 6.19 <0.001
Current smoker (-) 10 Reference - Reference -
Ex- smoker(+) 4 0.44 0.16 0.31 0.058
Ex- smoker (-)a 14 Reference - Reference -
Ex-smoker 14 5.25 0.011 4.36 0.071
Current smoker 4 11.76 <0.001 12.5 <0.001
Never smoker 6 Reference - Reference -
Passive smoking history
Passive smoker in childhood(+) 13 1.23 0.613 1.08 0.84
Passive smoker in childhood(-) 11 Reference - Reference -
a ex-smoker (-) = current smoker.
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types, and lung diseases41; therefore, it is necessary to take 
steps to reduce tobacco use in all age groups. 
Conclusion
The prevalence of CB among adults in Khameneh city 
was slightly lower than that in other cities of Iran, such as 
Isfahan and Tehran. One reason for this difference might 
be high levels of air pollution in these big cities. However, 
the prevalence of smoking in Khameneh is high, because 
one-third of the men in the city are smokers. Given the 
importance of smoking as a major risk factor for several 
diseases and cancers, it is imperative that the authorities take 
preventive measures to reduce smoking in all age groups.
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